Results 111 to 120 of about 3,959 (186)

In vitro trypanocidal activity of the anti-helminthic drug nichlosamide

open access: yes, 2008
Only a few drugs are available for chemotherapy of African trypanosomiasis and there is an urgent need for the development of new anti-trypanosomal agents.
Merschjohann, Karin, Steverding, Dietmar
core   +1 more source

Identification of Potential Trypanosoma cruzi Trans-Sialidase Inhibitors by Computational Drug Repositioning Approaches

open access: yesScientia Pharmaceutica
Chagas disease, caused by the parasitic protozoan Trypanosoma cruzi (T. cruzi), represents a worldwide public health issue. To date, there is no efficient treatment to combat this pathology, and the only drugs available are usually toxic to the patient ...
Miguel A. Uc-Chuc   +5 more
doaj   +1 more source

Trypanocidal properties of <i>Terminalia ivorensis</i> A. Chev. (Combretaceae)

open access: yes, 2006
Human African Trypanosomiasis (sleeping sickness) cause considerable mortality and morbidity throughout the world with Trypansoma brucei, T. gambiense and T. brucei rhodesiense as the major causative agents.
Joseph M Agbedahunsi   +10 more
core   +1 more source

Synthesis, in vitro cytotoxicity and trypanocidal evaluation of novel 1, 3, 6-substituted non-fluoroquinolones

open access: yes, 2018
Sleeping sickness (trypanosomiasis) is a neglected tropical disease that affects mostly the poorest communities in sub-Saharan Africa. Toxic side effects associated with the use of current anti-trypanosomal drugs, which in some cases kill faster than the
Mtshare, Thanduxolo Elihle   +15 more
core   +1 more source

Trypanocidal activity of a thioacyl-thiosemicarbazide derivative associating both immunostimulating thalidomide and anti-parasitic thiosemicarbazide pharmacophores

open access: yes, 2015
African trypanosomiasis remains a life-threatening disease and there is nowadays an urgent need for improved therapeutic agents for this pathology.
Kassehin, Comlan Urbain   +3 more
core  

In vitro trypanocidal activity of DB745B and other novel arylimidamides against Trypanosoma cruzi

open access: yes, 2011
OBJECTIVES: As part of a search for new therapeutic opportunities to treat chagasic patients, in vitro efficacy studies were performed to characterize the activity of five novel arylimidamides (AIAs) against Trypanosoma cruzi.
Junqueira, Angela   +8 more
core  

Design, Synthesis, and Trypanocidal Activity of Novel 5-Nitroimidazolyl O -Benzyloxime Ethers

open access: yes, 2017
In this paper, we describe the synthesis and the action against of the trypomastigote form of Trypanosoma cruzi of a new class of nitroimidazole-2-carbaldehyde O-benzyloximes.
Edson Ferreira da Silva   +15 more
core   +1 more source

Natural and semisynthetic analogues of manadoperoxide b reveal new structural requirements for trypanocidal activity

open access: yes, 2018
Chemical analysis of the Indonesian sponge Plakortis cfr. lita afforded two new analogues of the potent trypanocidal agent manadoperoxide B (1), namely 12-isomanadoperoxide B (2) and manadoperoxidic acid B (3).
Tasdemir, Deniz   +7 more
core  

Gossypol: a potential trypanocidal agent [PDF]

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 1985
openaire   +3 more sources

Structural planning, synthesis and evaluation of properties trypanocidal aryl-1,3-thiazoles

open access: yes, 2016
FACEPE, CAPES, CNPq.Chagas disease is a parasitic infection caused by protozoan T. cruzi, which affects around 7 million people worldwide. Benznidazole (BZD) is the sole drug approved for treatment during the acute and asymptomatic chronic phases ...
Oliveira, Ulisses José Félix Tenório de   +9 more
core  

Home - About - Disclaimer - Privacy